Biotin in multiple sclerosis in real world: a cohort of 50 patients

被引：0
|
作者：
Fromont, A. [1 ]
Romain, G. [2 ]
Vialatte, A. L. [1 ]
Maugest, L. [1 ]
Audry, D. [1 ]
Moreau, T. [1 ]
机构：
[1] Univ Hosp Dijon, Neurol, Dijon, France
[2] Univ Hosp Dijon, Epidemiol, Dijon, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P747
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [21] Real world experience with ocrelizumab in patients with primary progressive multiple sclerosis
    Lopez Ruiz, R.
    Dotor Garcia-Soto, J.
    Hiraldo, J. D. G.
    Ruiz-Pena, J. L.
    Paramo Camino, M. D.
    Ruiz De Arcos, M.
    Navarro Mascarell, G.
    Eichau Madueno, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 301 - 302
  • [22] Predictors of self-reported fatigue in a large real world multiple sclerosis cohort
    Englund, S.
    Kierkegaard, M.
    Longinetti, E.
    Frisell, T.
    Piehl, F.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 256 - 257
  • [23] Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
    Milanov, Ivan
    Ivanova, Sonya
    Tournev, Ivailo
    Chamova, Teodora
    Kaprelyan, Ara
    Slavov, Georgi
    Chervenkov, Vitan
    Kipriyanovska, Katerina
    REVISTA DE NEUROLOGIA, 2023, 77 : S1 - S7
  • [24] Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry
    Papp, Viktoria
    Buron, Mathias Due
    Siersma, Volkert
    Rasmussen, Peter Vestergaard
    Illes, Zsolt
    Kant, Matthias
    Hilt, Claudia
    Mezei, Zsolt
    Roshanisefat, Homayoun
    Sejbaek, Tobias
    Weglewski, Arkadiusz
    van Wingerden, Janneke
    Geertsen, Svend Sparre
    Bramow, Stephan
    Sellebjerg, Finn
    Magyari, Melinda
    PLOS ONE, 2021, 16 (05):
  • [25] Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: results from ms paths
    Hersh, C.
    Kieseier, B.
    De Moor, C.
    Miller, D.
    Campagnolo, D.
    Williams, J.
    Fitzgerald, K.
    Xiong, K.
    Mcginley, M.
    Hyland, M.
    Rudick, R.
    Ziemssen, T.
    Koulinska, I.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 609 - 609
  • [26] Comparison of symptoms, treatments and healthcare resource utilization in patients with multiple sclerosis by sex in a real world cohort in the United States
    Topuria, Ia
    Cavanaugh, Cristi
    Donadio, Greg
    Starzyk, Kathryn
    Gliklich, Rich
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 309 - 309
  • [27] Infectious risk stratification in a cohort of Italian multiple sclerosis patients: real world data from San Raffaele Hospital
    Zanetta, C.
    Goletti, D.
    Sangalli, F.
    Colombo, B.
    Pisa, M.
    Dalla Costa, G.
    Gelibter, S.
    Martinelli, V.
    Comi, G.
    Filippi, M.
    Moiola, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 871 - 871
  • [28] Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS
    Hersh, Carrie M.
    Kieseier, Bernd
    de Moor, Carl
    Miller, Deborah M.
    Campagnolo, Denise
    Williams, James R.
    Fitzgerald, Kathryn C.
    Xiong, Kuangnan
    McGinley, Marisa P.
    Hyland, Megan
    Rudick, Richard A.
    Ziemssen, Tjalf
    Koulinska, Irene
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (02)
  • [29] Managing laboratory interferences with biotin in multiple sclerosis patients treated with high doses of biotin
    Gudesblatt, M.
    Srinivasan, J.
    Jaenicke, K.
    Fafard, L.
    Bumstead, B.
    Buhse, M.
    Golan, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 573 - 574
  • [30] A Real World Data of Ocrelizumab in Multiple Sclerosis
    Beckmann, Y.
    Uzunkopru, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 671 - 671
12345